A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

NCT01429792 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1013

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: peginterferon alfa-2a [Pegasys]
DRUG: ribavirin [Copegus]

Sponsor

Hoffmann-La Roche